Dr. Derry Ridgway, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 251 Maple St Ste B, Ashland, OR 97520 Phone: 949-646-1016 |
Debra L. Koutnik, MD Pediatrics - Developmental – Behavioral Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 628 N Main St, Ashland, OR 97520 Phone: 541-201-4930 Fax: 541-201-4931 |
Richard Allen Tripoli, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 690 Spring Creek Dr, Ashland, OR 97520 Phone: 541-482-0872 |
Diane C. Williams, MD Pediatrics - Pediatric Hematology-Oncology Medicare: Not Enrolled in Medicare Practice Location: 99 Central Ave, Ashland, OR 97520 Phone: 541-482-9741 Fax: 541-488-6141 |
Donna M Bradshaw, MD Pediatrics - Pediatric Hematology-Oncology Medicare: Accepting Medicare Assignments Practice Location: 628 N Main St, Ashland, OR 97520 Phone: 541-201-4930 Fax: 541-201-4931 |
News Archive
Melanoma of the eye frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients live for a year. Now, final results from a phase III study have demonstrated that a new treatment significantly extends the time patients can live without the disease progressing.
An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine. An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance called Eprotirome in patients with high cholesterol.
HIV is spreading in New York City at about three times the national rate, with an incidence of 72 new HIV infections per 100,000 people, compared with 23 new infections per 100,000 people nationwide, according to a study released Wednesday by the New York City Department of Health and Mental Hygiene, the New York Times reports (Chan, New York Times, 8/28).
A scholarly article on wireless safety, published online in the Journal of Microscopy and Ultrastructure, reports that children and fetuses are the most at risk from neurological and biological damage that results from microwave radiation emitted by wireless devices, due to the higher rate of absorption of microwave radiation by children than by adults.
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
› Verified 6 days ago